Replies to post #8239 on Theriva Biologics Inc (TOVX)

[BooDog]

Synthetic Biologics Announces Washington University School of Medicine in St. Louis IRB Approval of the SYN-004 (ribaxamase) Phase 1b/2a Clinical Protocol

December 22, 2020
https://finance.yahoo.com/news/synthetic-biologics-announces-washington-university-120000078.html


2,219,019 shares of Common Stock issuable upon exercise of warrants* (see Item 4)

Let's see some real progress with SYN. $3 ++++ potential imo.